(lp0
S'SHAREHOLDER NOTICE: Khang &amp; Khang LLP Announces Securities Class Action ... Yahoo Finance - Feb 6, 2017 IRVINE, CA / ACCESSWIRE / March 21, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Stemline Therapeutics, Inc.  . Investors, who purchased or otherwise acquired Stemline&nbsp;...'
p1
aS'Why Stemline Therapeutics Inc Stock Is Climbing Today Motley Fool - Jan 6, 2017 The biotech stock rollercoaster known as Stemline Therapeutics Inc  popped Friday morning with a 21.8% gain, and it was still up about 14.5% as of 11:44 a.m.Stemline Therapeutics  Spikes after announcing FDA Agreement - Economic Calendar'
p2
aS'Stemline Therapeutics Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Mar 16, 2017 NEW YORK, March 16, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today financial results&nbsp;...'
p3
aS"Here's Why Stemline Therapeutics Stock Fell 36.9% This Morning Motley Fool - Feb 2, 2017 Shares of Stemline Therapeutics  tumbled nearly 37% this morning after investors learned that a patient died in a clinical trial involving its lead drug candidate, SL-401."
p4
aS'Stemline Therapeutics to Present at the Cowen and Company 37th Annual Health ... GlobeNewswire  - Feb 21, 2017 NEW YORK, March 02, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today that Ivan&nbsp;...'
p5
aS"ALERT: Rosen Law Firm Reminds Stemline Therapeutics, Inc. Investors of ... Yahoo Finance - Mar 13, 2017 NEW YORK, March 13, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Stemline Therapeutics, Inc. securities :  pursuant and/or traceable to Stemline's secondary public offering on or about&nbsp;..."
p6
aS"Wedbush Weighs in on Stemline Therapeutics Inc's FY2020 Earnings  The Cerbat Gem - 10 hours ago Stemline Therapeutics logo Stemline Therapeutics Inc  - Equities researchers at Wedbush reduced their FY2020 EPS estimates for Stemline Therapeutics in a research report issued on Friday.Ladenburg Thalmann Financial Services Analysts Give Stemline Therapeutics Inc ... - Petro Global News 24Analysts Issue Forecasts for Stemline Therapeutics Inc's FY2020 Earnings  - Chaffey Breeze"
p7
aS"Newman Ferrara LLP Announces Corporate Governance Investigation of Stemline ... Yahoo Finance - Feb 14, 2017 Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Stemline Therapeutics Inc.   into potential breaches of fiduciary duty by the Company's Board of Directors ...Newman Ferrara LLP Announces Corporate Governance Investigation of OvaScience ... - Business Wire "
p8
aS'Shareholder Deadline Reminder : Johnson &amp; Weaver, LLP Announces ... PR Newswire  - Mar 17, 2017 SAN DIEGO, March 17, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson &amp; Weaver, LLP  announces the filing of a class action lawsuit on behalf of purchasers of Stemline Therapeutics, Inc.  between January 6, 2017 and&nbsp;...'
p9
aS'Stemline Therapeutics,Inc.  Files An 8-K Results of Operations ... Market Exclusive - Mar 17, 2017 Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics.Stemline Therapeutics Inc.  Moves Lower on Volume Spike for March 17 - Equities.comHot Stocks Report: Kopin Corporation , Stemline Therapeutics, Inc.  - Post Analyst'
p10
a.